PHARMA MAR SA
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Public
- Established
- 1986-01-01
- Employees
- 251
- Market Cap
- $788.5M
- Website
- http://www.pharmamar.com
Clinical Trials
54
Active:42
Completed:4
Trial Phases
3 Phases
Phase 1:34
Phase 2:1
Phase 3:5
Drug Approvals
1
EMA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (41 trials with phase data)• Click on a phase to view related trials
Phase 1
34 (82.9%)Phase 3
5 (12.2%)phase_1_2
1 (2.4%)Phase 2
1 (2.4%)A Phase 3, Multicentre, Randomised, Controlled Trial to Determine the Efficacy and Safety of Two Dose Levels of Plitidepsin Versus Control in Adult Patients Requiring Hospitalisation for Management of Moderate COVID-19 Infectio
Phase 3
Not yet recruiting
- Conditions
- 07.1 COVID-19, virusCOVID-19, virusU07.1
News
New Global Clinical Trials Report Reveals Comprehensive Landscape of Ewing Sarcoma Research in 2025
A new comprehensive report on Ewing Sarcoma clinical trials provides critical insights into global research trends, trial distribution, and enrollment patterns across G7 and E7 countries.